KIDS - OrthoPediatrics Corp.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
47.80
+0.11 (+0.23%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close47.69
Open48.04
Bid31.00 x 1000
Ask47.82 x 800
Day's Range46.88 - 48.04
52 Week Range28.19 - 51.48
Volume89,070
Avg. Volume90,282
Market Cap799.34M
Beta (5Y Monthly)0.28
PE Ratio (TTM)N/A
EPS (TTM)-0.76
Earnings DateNov 06, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est50.50
  • GlobeNewswire

    OrthoPediatrics Corp. Reports Preliminary Unaudited Revenue for Fourth Quarter and Record Setting Full Year 2019

    WARSAW, Ind., Jan. 13, 2020 -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today.

  • GlobeNewswire

    OrthoPediatrics Corp. Announces Divestiture of the Vilex Adult Business

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it has completed the sale of substantially all of the assets related to the adult product offering of Vilex in Tennessee, Inc. (“Vilex Adult Business”) to Vilex LLC (“Buyer”), an affiliate of Squadron Capital LLC (“Squadron Capital”). In addition, Buyer was granted a license to manufacture and sell products utilizing the external fixation technology developed by Orthex, LLC, an affiliate of OrthoPediatrics, subject to certain restrictions in favor of OrthoPediatrics on sales to certain pediatric accounts.

  • Is OrthoPediatrics Corp. (KIDS) A Good Stock To Buy?
    Insider Monkey

    Is OrthoPediatrics Corp. (KIDS) A Good Stock To Buy?

    Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the third quarter. You can find articles about an individual hedge fund's trades on numerous financial […]

  • GlobeNewswire

    OrthoPediatrics Corp. Announces U.S. Launch of QuickPack™

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, is pleased to announce the U.S. launch of QuickPack™, a fully synthetic bone graft substitute featuring a high viscosity, calcium phosphate cement that closely mimics the mineral phase of natural bone. With mechanical properties close to those of cancellous bone, QuickPack produces a calcium-deficient apatite that has similar composition and structure to natural bone mineral.

  • GlobeNewswire

    OrthoPediatrics Corp. Announces Closing of Common Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today the closing of its underwritten follow-on public offering of 1,805,500 shares of its common stock at a price to the public of $36.50 per share, which included the exercise in full by the underwriters of their option to purchase additional shares of common stock on the same terms and conditions. 1,755,500 of the shares were offered by OrthoPediatrics and 50,000 shares were offered by certain selling stockholders. Gross proceeds to OrthoPediatrics were approximately $64.1 million, before deducting underwriting discounts and commissions and offering expenses payable by OrthoPediatrics.

  • GlobeNewswire

    OrthoPediatrics Corp. Announces Pricing of Offering of Common Stock

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the pricing of its underwritten public offering of 1,570,000 shares of its common stock at a price to the public of $36.50 per share. 1,520,000 of the shares are being offered by OrthoPediatrics and 50,000 shares are being offered by certain selling stockholders. OrthoPediatrics will not receive any proceeds from the sale of the shares by the selling stockholders.

  • GlobeNewswire

    OrthoPediatrics Corp. Announces Proposed Public Offering of Common Stock

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that it is commencing an underwritten public offering of its common stock. OrthoPediatrics and certain of its stockholders are proposing to sell shares of common stock, including shares to be offered by certain selling stockholders. OrthoPediatrics will not receive any proceeds from the sale of the shares by the selling stockholders.

  • GlobeNewswire

    OrthoPediatrics Corp. to Sponsor the Annual International Pediatric Orthopaedic Symposium (IPOS)

    The Company will sponsor a pre-course meeting in addition to five spotlight sessions on a variety of topics WARSAW, Ind., Nov. 20, 2019 -- OrthoPediatrics Corp..

  • When Will OrthoPediatrics Corp. (NASDAQ:KIDS) Breakeven?
    Simply Wall St.

    When Will OrthoPediatrics Corp. (NASDAQ:KIDS) Breakeven?

    OrthoPediatrics Corp.'s (NASDAQ:KIDS): OrthoPediatrics Corp., a medical device company, designs, develops, and markets...

  • GlobeNewswire

    OrthoPediatrics Corp. Announces U.S. Launch of PediFoot Deformity Correction System

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, is pleased to announce the domestic launch of the PediFoot Deformity Correction System (“PediFoot”), following 510(k) clearance by the U.S. Food and Drug Administration (FDA) in August. The PediFoot system is the first pediatric-specific system to treat deformities of the foot. Within the OrthoPediatrics product portfolio, this system offers the smallest plates and screws, which enable greater effectiveness in addressing cavus foot, flatfoot, clubfoot, and hallux valgus foot deformities.

  • GlobeNewswire

    OrthoPediatrics Corp. to Present at Two Upcoming Investor Conferences

    WARSAW, Ind., Nov. 11, 2019 -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively on advancing the field of pediatric.

  • OrthoPediatrics Corp. (KIDS): Hedge Funds In Wait-and-See Mode
    Insider Monkey

    OrthoPediatrics Corp. (KIDS): Hedge Funds In Wait-and-See Mode

    We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 45% and 39% respectively. Hedge funds' top 3 stock picks returned 34.4% this year and beat the S&P […]

  • OrthoPediatrics (KIDS) Reports Q3 Loss, Tops Revenue Estimates
    Zacks

    OrthoPediatrics (KIDS) Reports Q3 Loss, Tops Revenue Estimates

    OrthoPediatrics (KIDS) delivered earnings and revenue surprises of -5.88% and 4.68%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    OrthoPediatrics Corp. Reports Third Quarter 2019 Financial Results

    Record quarterly revenue of $20.7 million, up 31.1% year-over-year WARSAW, Ind., Nov. 07, 2019 -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company focused.

  • Analysts Estimate OrthoPediatrics (KIDS) to Report a Decline in Earnings: What to Look Out for
    Zacks

    Analysts Estimate OrthoPediatrics (KIDS) to Report a Decline in Earnings: What to Look Out for

    OrthoPediatrics (KIDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Earnings Preview: OrthoPediatrics (KIDS) Q3 Earnings Expected to Decline
    Zacks

    Earnings Preview: OrthoPediatrics (KIDS) Q3 Earnings Expected to Decline

    OrthoPediatrics (KIDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GlobeNewswire

    OrthoPediatrics Corp. to Report Third Quarter 2019 Financial Results on November 7, 2019

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its third quarter 2019 financial results on Thursday, November 7, 2019, after the market closes. OrthoPediatrics will host a conference call on Friday, November 8, 2019, at 8:00 a.m. ET to discuss the results. The dial-in numbers are (855) 289-4603 for domestic callers and (614) 999-9389 for international callers.

  • GlobeNewswire

    OrthoPediatrics Corp. to Participate at the Cantor Fitzgerald Global Healthcare Conference

    WARSAW, Ind., Sept. 25, 2019 -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively on advancing the field of pediatric.

  • GlobeNewswire

    OrthoPediatrics Corp. to Sponsor Three Medical Meetings in September 2019

    WARSAW, Ind., Sept. 16, 2019 -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics,.

  • Is OrthoPediatrics (NASDAQ:KIDS) Using Too Much Debt?
    Simply Wall St.

    Is OrthoPediatrics (NASDAQ:KIDS) Using Too Much Debt?

    Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...

  • GlobeNewswire

    OrthoPediatrics Corp. Announces U.S. Launch of Next Generation Cannulated Screw Systems

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, is pleased to announce the U.S. launch of the next generation Cannulated Screw Systems for treating pediatric patients with fractures and fusions, following 510(k) clearance by the U.S. Food and Drug Administration in July. The new, innovative systems include expanded screw sizes that provide pediatric orthopedic surgeons additional intra-operative convenience. The systems were designed specifically for children by pediatric orthopedic surgeons with a high level of focus on extraction instrumentation.

  • GlobeNewswire

    OrthoPediatrics Corp. Receives FDA 510(k) Clearance for First Pediatric-Specific Foot System

    WARSAW, Ind., Aug. 19, 2019 -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics,.

  • OrthoPediatrics Corp. (KIDS) Q2 2019 Earnings Call Transcript
    Motley Fool

    OrthoPediatrics Corp. (KIDS) Q2 2019 Earnings Call Transcript

    KIDS earnings call for the period ending June 30, 2019.

  • OrthoPediatrics (KIDS) Reports Q2 Loss, Lags Revenue Estimates
    Zacks

    OrthoPediatrics (KIDS) Reports Q2 Loss, Lags Revenue Estimates

    OrthoPediatrics (KIDS) delivered earnings and revenue surprises of -55.56% and -0.73%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    OrthoPediatrics Corp. Reports Second Quarter 2019 Financial Results

    WARSAW, Ind., Aug. 07, 2019 -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced.